Sign in
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology
Journal article   Open access  Peer reviewed

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology

N A Mark Estes, 3rd, Richard J Kovacs, Aaron L Baggish, Robert J Myerburg and Amer Coll Cardiology
Journal of the American College of Cardiology, Vol.66(21), pp.2429-2433
2015-12-01
PMID: 26542661

Abstract

Performance-Enhancing Substances - administration & dosage United States - epidemiology Cardiovascular Abnormalities - complications Practice Guidelines as Topic - standards Humans Male Cardiology - standards Advisory Committees - standards Athletes Cardiovascular Abnormalities - diagnosis Cardiovascular Abnormalities - drug therapy American Heart Association Young Adult Adolescent Adult Female Child Dietary Supplements
url
https://doi.org/10.1016/j.jacc.2015.09.043View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.141 Hormone Therapy
1.141.1092 Testosterone
Web Of Science research areas
Cardiac & Cardiovascular Systems
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details